Search for: "Bristol-Meyers Squibb Co" Results 21 - 40 of 42
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2015, 8:47 pm by Mark Summerfield
  The drug is marketed in Australia by Bristol-Meyers Squibb (BMS) as ABILIFY, under license from the patentee Otsuka Pharmaceutical Co., Ltd.The Full Court has upheld the earlier finding of a single judge of the court that the patent is valid, notwithstanding that there is prior art teaching which, if carried out in a particular manner, could result in the claimed product. [read post]
20 Oct 2014, 10:00 pm by Courtenay C. Brinckerhoff
On October 20, 2014, the Federal Circuit issued an order denying the petition for rehearing or rehearing en banc filed in Bristol-Meyers Squibb Co. v. [read post]
5 Jun 2013, 5:29 am by Schachtman
Bristol-Meyers Squibb Co., 1998 WL 812318, at *23 (M.D. [read post]
18 Apr 2012, 4:40 pm by Schachtman
Bristol-Meyers Squibb Co., 1998 WL 812318, at *23 (M.D. [read post]
3 Apr 2012, 1:00 am by Courtenay Brinckerhoff
The USPTO has filed a motion requesting reconsideration in Bristol Meyers Squibb Co. v. [read post]
28 Mar 2012, 1:31 am by Mark Summerfield
  This time the drug in question is ‘atypical’ antipsychotic aripiprazole, marketed by Bristol-Meyers Squibb (BMS) as ABILIFY, under license from the patentee Otsuka Pharmaceutical Co., Ltd. [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Bristol-Meyers Squibb Co. and Otsuka America Pharmaceutical, Inc., No. 12-cv-01124 (E.D.N.Y., Mar. 7, 2012) (Complaint) [read post]
3 Mar 2012, 5:36 pm by Schachtman
Bristol-Meyers Squibb Co., 1998 WL 812318, at *23 (M.D. [read post]
14 Jun 2011, 7:01 am by Alexander Gibson
The Class Actions Post-Concepcion: A Defining Moment in American Jurisprudence Whatever happened to state’s rights, Justice Scalia? [read post]
9 Mar 2011, 11:14 am by PaulKostro
Bristol-Meyers Squibb Co., 156 N.J. 455, 463 (1998) (quoting N.J.R.E. 803(b)(4)). [read post]
18 Feb 2011, 11:47 am by Sheppard Mullin
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
13 May 2010, 12:27 pm by Bexis
Bristol-Myers Squibb Co., 2009 WL 5216984 (D.N.J. [read post]
7 Sep 2009, 12:06 pm
Eighteen months after the auction rate securities markets collapsed when Wall Street withdrew its support, companies like Bristol-Myers Squibb Co., Texas Instruments, Corning, and Teva Pharmaceuticals are still suffering from the Wall Street debacle. [read post]
17 Jul 2009, 2:29 pm
(Lynnfield, MA; Constantine Kalogianis, President) Adnexus, A Bristol-Myers Squibb R&D Company (Waltham, MA; Sonia Vora, President) Advanced Beauty Corporation (Braintree, MA; Hanna Le, President) Advanced Integrated Solutions Corp. [read post]